Boston Scientific Corporation Finds Clot Risk With Stent

September 7, 2006 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

NEW YORK, Sept 7 (Reuters) - Boston Scientific Corp. (BSX.N: Quote, Profile, Research) said on Thursday that a new internal analysis of its clinical data confirms an increased risk of blood clots with its drug-coated cardiac stent.

>>> Discuss This Story

Twitter
LinkedIn
Facebook
Email
Print